Analyst Reco. MaaT Pharma

Equities

Market Closed - Euronext Paris Other stock markets 08:10:53 03/05/2024 pm IST			5-day change	1st Jan Change
9.4 ^EUR	+1.95%		+3.75%	+34.67%

15/04	MaaT Pharma: positive data in graft-versus-host disease	CF
15/04	MaaT Pharma Presents Positive 18-Month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event	CI

Fragmented feeling?	06/11
But where have the bears gone?	03/11
MaaT Pharma's Immune Disorder Therapy Shows Improved Survival Rate In Clinical Trials	13/21/13	MT

No results for this search